RecruitingNot ApplicableNCT07644624

Sling vs. Dynamic Shoulder Stabilizer After Soft Tissue Shoulder Instability Surgery (SLIDY)

Sling vs. Dynamic Shoulder Stabilizer After Soft Tissue Shoulder Instability Surgery ("SLIDY"): A Pilot Randomized Controlled Trial Assessing Feasibility, Early Functional Recovery, and Structural Healing


Sponsor

Hospital Universitari de Bellvitge

Enrollment

40 participants

Start Date

Jun 15, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized controlled trial seeks to address a significant clinical gap by evaluating the outcomes of two postoperative immobilization methods following arthroscopic soft tissue surgery for anterior shoulder instability: a standard static arm sling and a dynamic shoulder orthosis.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Adults aged ≥18 years undergoing arthroscopic soft-tissue stabilization for anterior shoulder instability (Bankart repair ± Hill-Sachs remplissage).
  • Ability and willingness to comply with the study protocol and scheduled follow-ups.
  • Provision of written informed consent.

Exclusion Criteria5

  • Significant glenoid bone loss requiring bony augmentation procedures (e.g., bone block procedures, Latarjet).
  • Concomitant rotator cuff repair or fracture fixation.
  • Contraindication to MRI (e.g., pacemaker, claustrophobia, incompatible implants).
  • Cognitive impairment, language barriers, or logistical inability to attend follow-up visits.
  • Previous ipsilateral shoulder surgery.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDynamic Immobilizer

An adjustable strap system applied immediately post-surgery that permits movement of the shoulder joint while simultaneously limiting potentially harmful ranges of motion and translations. It is worn continuously for 3 weeks.

DEVICEConventional fabric arm sling

Static immobilization using a conventional fabric arm sling applied immediately post-surgery and worn continuously for 3 weeks.


Locations(1)

Bellvitge University Hospital

L'Hospitalet de Llobregat, Catalonia, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07644624


Related Trials